Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2020-02-14
4:14 pm
Sale		13GAevi Genomic Medicine LLC
GNMX		BAKER BROS. ADVISORS LP564,844
0.7%		-3,385,575decrease
(-85.70%)		View
2020-02-12
4:28 pm
Sale		13GAevi Genomic Medicine LLC
GNMX		ADAGE CAPITAL PARTNERS GP L.L.C.423,633
0.54%		-5,076,367decrease
(-92.30%)		View
2020-02-07
12:56 pm
Purchase		13DAevi Genomic Medicine LLC
GNMX		ASTRAZENECA PLC12,946,900
16.7%		12,946,900increase
(New Position)		View
2020-01-06
4:06 pm
Purchase		13DAevi Genomic Medicine LLC
GNMX		Children's Hospital of Philadelphia Foundation57,280,927
49.1%		6,473,450increase
(+12.74%)		View
2019-12-06
5:18 pm
Purchase		13DAevi Genomic Medicine LLC
GNMX		Children's Hospital of Philadelphia Foundation50,807,477
52.3%		4,661,074increase
(+10.10%)		View
2019-11-20
4:30 pm
Purchase		13DAevi Genomic Medicine LLC
GNMX		Children's Hospital of Philadelphia Foundation46,146,403
47.5%		24,834,817increase
(+116.53%)		View
2019-10-22
4:59 pm
Unchanged		13DAevi Genomic Medicine LLC
GNMX		Children's Hospital of Philadelphia Foundation21,311,586
31.5%		0
(Unchanged)		View
2019-03-29
5:27 pm
Purchase		13DAevi Genomic Medicine LLC
GNMX		Children's Hospital of Philadelphia Foundation21,311,586
31.5%		63,333increase
(+0.30%)		View
2019-02-13
4:29 pm
Sale		13GAevi Genomic Medicine LLC
GNMX		BAKER BROS. ADVISORS LP3,950,419
6.1%		-104,723decrease
(-2.58%)		View